Gestala is the latest company to emerge from China’s burgeoning brain-computer interface industry. It plans to access the brain with noninvasive ultrasound technology.
As China released a high-tech medical device to help some 23 million children suffering from attention deficit hyperactivity ...
Forbes contributors publish independent expert analyses and insights. A former tech executive covering AI, XR and The Metaverse for Forbes. At CES 2026, LumiMind presented its brand new closed-loop ...
Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...
OpenAI (OPENAI) announced on Thursday that it has invested in brain computer interface startup Merge Labs, which includes OpenAI CEO Sam Altman as an investor. Brain computer interfaces, or BCIs, ...
What Is Mr. House’s Brain-Computer Interface Implant Chip, and How Is It Introduced? Mr. House’s Brain-Computer Interface Implant Chip is one of the first things we see on Fallout season two. We learn ...
Discover how Noland Arbaugh, the first human with a Neuralink chip, controls computers with his thoughts. Learn about the ...
Sam Altman is adding a brain-computer interface startup to his growing portfolio of startups outside of OpenAI. Andrew Harnik/Getty Images Co-founded by Altman, Merge is a brain-computer interface ...
Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...
Fallout season two kicked off with a bang… Literally, if you’re one of a few unlucky people who cross paths with Mr. House or Hank MacLean. But what is it that’s making people’s heads go bang? We have ...
Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market The Company stated that these ...
Recent breakthroughs in brain-computer interface tech are starting to pay off with amazing success in medical trials, and ...